SCHEMBL15927701

SCHEMBL15927701

Cc1cc(F)c([N+](=O)[O-])cc1C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
ATM Q13315 1/20 0.43
ESPL1 Q14674 1/20 0.42
ALDH1A1 P00352 4/20 0.42
HIF1A Q16665 1/20 0.42
VCAM1 P19320 1/20 0.40
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
PDK1 Q15118 1/20 0.39
HSD17B10 Q99714 1/20 0.37
TSHR P16473 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
RECQL P46063 1/20 0.37
GPR35 Q9HC97 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12413958 0.81 ATM (0.46) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL12593915 0.81 TDP1 (0.52) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL397387 0.79 ATM (0.50) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL29805163 0.79 TDP1 (0.50) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL187542 0.79 TDP1 (0.50) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL5953091 0.79 TSHR (0.49) TDP1ALDH1A1MEN1KMT2APDK1
SCHEMBL10673642 0.79 GPR35 (0.44) TDP1ALDH1A1HIF1AMEN1RAB9A
SCHEMBL13395143 0.78 TDP1 (0.42) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL26137537 0.78 PDK1 (0.44) TDP1ATMESPL1ALDH1A1HIF1A
SCHEMBL57522 0.77 ALOX15 (0.46) TDP1ATMESPL1ALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160075724-A1 CETP Inhibitors MERCK SHARP & DOHME (US) 2016-03-17 US disclosed
US-20140221383-A1 CETP INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221383-A1 CETP INHIBITORS CETP, APOB, MTTP TDP1 1006/4885ATM 1904/4885ESPL1 3416/4885
US-20160075724-A1 CETP Inhibitors CETP, APOB, MTTP TDP1 1006/4885ATM 1904/4885ESPL1 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.